jRCT1050220134招募中不适用
Long-term observational study for pediatric brain tumors (PBT-LTFU)
Department of pediatric hematology and oncology, Osaka City General Hospital0 个研究点目标入组 1,000 人开始时间: 2020年9月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0age over 至 30age old not（—）
- 性别
- All
入选标准
- •Patients with brain tumors younger than 30 years old at diagnosis (histology is not limited).
- •Registration of the JCCG pediatric solid tumor observation study has been completed at the time of participation in this study.
- •Registration for the other prospective interventional study for pediatric brain tumors conducted by JCCG is completed.
- •At the same time as this study, the patient is enrolled or will be enrolled in a prospective clinical study conducted by the JCCG Brain Tumor Committee.
- •Written informed consent from the patient and/or legally acceptable proxy has been obtained.
排除标准
- •Patients who are unable to evaluate the late effects.
结局指标
主要结局
-
Overall survival rate at 20 years
次要结局
- Overall survival rates(5 and 10 years)
- Progression-free survival rate(5 and 10 years)
- Rate of secondary neoplasms
- Social outcomes
- Rate of late complications
- Rate and causes of late mortalities
研究者
相似试验
招募中
Unknown
ong-term observational study for pediatric brain tumorsPediatric brain tumorD001932brain tumorJPRN-jRCT1050220134Fujisaki Hiroyuki1,000
招募中
Unknown
A prospective observational study in child patients with RSV infectioRSV infectionJPRN-jRCT1030230252Ishiwada Naruhiko100
进行中（未招募）
不适用
A prospective observational study in child patients with RSV infectionjRCT1030230252Medical Mycology Research Center, Chiba University100
已完成
4 期
A prospective pediatric longitudinal evaluation to assess the long-term safety of tacrolimus ointment for the treatment of atopic dermatitis.10014982Atopic DermatitisNL-OMON30879Astellas Pharma120
招募中
不适用
Prospective Clinical Assessment Study in Children With HypochondroplasiaHypochondroplasiaNCT06410976QED Therapeutics, a BridgeBio company150